Soluble Trem2 is a Negative Regulator of Erythrophagocytosis After Intracerebral Hemorrhage in a CD36 Receptor Recycling Manner

Overview

Journal J Adv Res

Specialties General Medicine
Science

Date 2023 Feb 1

PMID 36725189

Authors

Hang Zhou

Jianru Li

Libin Hu

Jiahui Yu

Xiongjie Fu

Feng Liang

Feng Yan

Gao Chen

Affiliations

Soon will be listed here.

Abstract

Introduction: Microglia and macrophages participate in hematoma clearance after intracerebral hemorrhage (ICH), thereby facilitating tissue restoration and neurological recovery. Triggering receptor expressed on myeloid cells 2 (Trem2) has been indicated as a major pathology-induced immune signaling hub on the microglial/macrophage surface. Soluble Trem2 (sTrem2), the proteolytic form of Trem2, is abundant in the body fluid and is positively correlated with the pathological process.

Objectives: In the present study, we aimed to investigate the potential role of sTrem2 in hematoma resolution after ICH and to elucidate its underlying mechanisms.

Methods: We explored the biological functions of sTrem2 in the murine ICH brain by stereotaxic injection of recombinant sTrem2 protein or by adeno-associated virus-mediated expression. Erythrocyte phagocytosis was assessed using flow cytometry and immunofluorescence. Western blotting was performed to evaluate protein expression. Changes in behavior, sTrem2-induced down-stream pathway, and microglia were examined.

Results: sTrem2 impedes hematoma resolution and impairs functional motor and sensory recovery. Interestingly, sTrem2 bypasses full-length Trem2, negatively regulating microglial/macrophage erythrophagocytosis, and promotes an inflammatory phenotype, which is associated with reduced retromer levels and impaired recycling of the pro-erythrophagocytic receptor CD36. Rescue of retromer Vps35 abolishes the phagocytosis-inhibiting effects and lysosome-dependent CD36 degradation caused by sTrem2.

Conclusion: These findings indicate sTrem2 as a negative factor against microglia/macrophage-mediated hematoma and related neuronal damage clearance, provide insight into the mechanisms by which erythrophagocytosis is regulated and how it may be impaired after ICH, and suggest that the anti-proteolytic activity of Trem2 can be explored for ICH therapy.

Citing Articles

Microglial Mechanisms and Therapeutic Potential in Brain Injury Post-Intracerebral Hemorrhage.

Gong Y, Li H, Cui H, Gong Y J Inflamm Res. 2025; 18:2955-2973.

PMID: 40026311 PMC: 11872102. DOI: 10.2147/JIR.S498809.

Extracellular Vesicles From Bone Marrow-Derived Macrophages Enriched in ARG1 Enhance Microglial Phagocytosis and Haematoma Clearance Following Intracerebral Haemorrhage.

Hu L, Chen Z, Lu J, Jiang S, Lin H, Zhou J J Extracell Vesicles. 2025; 14(1):e70041.

PMID: 39868438 PMC: 11770371. DOI: 10.1002/jev2.70041.

Biochemical and biophysical mechanisms macrophages use to tune phagocytic appetite.

Bond A, Morrissey M J Cell Sci. 2025; 138(1).

PMID: 39749603 PMC: 11828473. DOI: 10.1242/jcs.263513.

Longitudinal associations between cerebrospinal fluid glial activation markers, depression, and dopamine transporter availability in patients with Parkinson's disease.

Yang D, Chen F, Ren J, Wang L, Zhu Z, Wu Z J Neurol. 2024; 272(1):23.

PMID: 39666148 DOI: 10.1007/s00415-024-12779-2.

Efferocytosis: the resolution of inflammation in cardiovascular and cerebrovascular disease.

Zhang B, Zou Y, Yuan Z, Jiang K, Zhang Z, Chen S Front Immunol. 2024; 15:1485222.

PMID: 39660125 PMC: 11628373. DOI: 10.3389/fimmu.2024.1485222.

References

Zhao X, Sun G, Zhang J, Strong R, Song W, Gonzales N . Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages. Ann Neurol. 2007; 61(4):352-62. DOI: 10.1002/ana.21097. View

Kwon H, Lee E, Park H, Jin J, Choi H, Lee K . Early increment of soluble triggering receptor expressed on myeloid cells 2 in plasma might be a predictor of poor outcome after ischemic stroke. J Clin Neurosci. 2020; 73:215-218. DOI: 10.1016/j.jocn.2020.02.016. View

Yamasaki R, Lu H, Butovsky O, Ohno N, Rietsch A, Cialic R . Differential roles of microglia and monocytes in the inflamed central nervous system. J Exp Med. 2014; 211(8):1533-49. PMC: 4113947. DOI: 10.1084/jem.20132477. View

Jing C, Bian L, Wang M, Keep R, Xi G, Hua Y . Enhancement of Hematoma Clearance With CD47 Blocking Antibody in Experimental Intracerebral Hemorrhage. Stroke. 2019; 50(6):1539-1547. PMC: 6538472. DOI: 10.1161/STROKEAHA.118.024578. View

Krishnamurthi R, Feigin V, Forouzanfar M, Mensah G, Connor M, Bennett D . Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet Glob Health. 2014; 1(5):e259-81. PMC: 4181351. DOI: 10.1016/S2214-109X(13)70089-5. View

Suarez-Calvet M, Kleinberger G, Caballero M, Brendel M, Rominger A, Alcolea D . sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers. EMBO Mol Med. 2016; 8(5):466-76. PMC: 5120370. DOI: 10.15252/emmm.201506123. View

Temkin P, Lauffer B, Jager S, Cimermancic P, Krogan N, Von Zastrow M . SNX27 mediates retromer tubule entry and endosome-to-plasma membrane trafficking of signalling receptors. Nat Cell Biol. 2011; 13(6):715-21. PMC: 3113693. DOI: 10.1038/ncb2252. View

Schlepckow K, Monroe K, Kleinberger G, Cantuti-Castelvetri L, Parhizkar S, Xia D . Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region. EMBO Mol Med. 2020; 12(4):e11227. PMC: 7136959. DOI: 10.15252/emmm.201911227. View

Zhuang J, Peng Y, Gu C, Chen H, Lin Z, Zhou H . Wogonin Accelerates Hematoma Clearance and Improves Neurological Outcome via the PPAR-γ Pathway After Intracerebral Hemorrhage. Transl Stroke Res. 2020; 12(4):660-675. DOI: 10.1007/s12975-020-00842-9. View

10.

Fassler M, Rappaport M, Cuno C, George J . Engagement of TREM2 by a novel monoclonal antibody induces activation of microglia and improves cognitive function in Alzheimer's disease models. J Neuroinflammation. 2021; 18(1):19. PMC: 7796541. DOI: 10.1186/s12974-020-01980-5. View

11.

Zhong L, Xu Y, Zhuo R, Wang T, Wang K, Huang R . Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer's disease model. Nat Commun. 2019; 10(1):1365. PMC: 6433910. DOI: 10.1038/s41467-019-09118-9. View

12.

Wilson E, Swarovski M, Linortner P, Shahid M, Zuckerman A, Wang Q . Soluble TREM2 is elevated in Parkinson's disease subgroups with increased CSF tau. Brain. 2020; 143(3):932-943. PMC: 7089668. DOI: 10.1093/brain/awaa021. View

13.

Pluvinage J, Haney M, Smith B, Sun J, Iram T, Bonanno L . CD22 blockade restores homeostatic microglial phagocytosis in ageing brains. Nature. 2019; 568(7751):187-192. PMC: 6574119. DOI: 10.1038/s41586-019-1088-4. View

14.

Zhou H, Hu L, Li J, Ruan W, Cao Y, Zhuang J . AXL kinase-mediated astrocytic phagocytosis modulates outcomes of traumatic brain injury. J Neuroinflammation. 2021; 18(1):154. PMC: 8264993. DOI: 10.1186/s12974-021-02201-3. View

15.

Bonifacino J, Hurley J . Retromer. Curr Opin Cell Biol. 2008; 20(4):427-36. PMC: 2833274. DOI: 10.1016/j.ceb.2008.03.009. View

16.

Ulland T, Colonna M . TREM2 - a key player in microglial biology and Alzheimer disease. Nat Rev Neurol. 2018; 14(11):667-675. DOI: 10.1038/s41582-018-0072-1. View

17.

Loftspring M, McDole J, Lu A, Clark J, Johnson A . Intracerebral hemorrhage leads to infiltration of several leukocyte populations with concomitant pathophysiological changes. J Cereb Blood Flow Metab. 2008; 29(1):137-43. PMC: 2710977. DOI: 10.1038/jcbfm.2008.114. View

18.

Damisah E, Rai A, Grutzendler J . TREM2: Modulator of Lipid Metabolism in Microglia. Neuron. 2020; 105(5):759-761. DOI: 10.1016/j.neuron.2020.02.008. View

19.

Heckmann B, Teubner B, Tummers B, Boada-Romero E, Harris L, Yang M . LC3-Associated Endocytosis Facilitates β-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer's Disease. Cell. 2019; 178(3):536-551.e14. PMC: 6689199. DOI: 10.1016/j.cell.2019.05.056. View

20.

Broderick J, Brott T, Duldner J, Tomsick T, Huster G . Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993; 24(7):987-93. DOI: 10.1161/01.str.24.7.987. View